How IDD has evolved: IDD’s development 
has been driven by the pharmaceutical industry’s transformation

“Over the past two decades, we have witnessed and contributed to the profound transformation of the pharmaceutical industry. By seizing the opportunities presented by this evolving landscape, we have established IDD as a key partner for pharmaceutical stakeholders.​ We have always been where it matters/innovators.”

Hélène Rouquette, Founder and Chairman, IDD

2003

Launching International Drug Development (IDD)

Building a strong reputation by assisting global sponsors with product development, regulatory strategies, and project management challenges.

2005

Building an in-house portfolio


Developing its own pipeline and launching its proprietary assets through partners or licenses

2024

Creating the Bio Valys Pharma platform

Creating an autonomous pharmaceutical platform to market essential medicines

Today

Becoming an integrated pharmaceutical and regulatory partner from medicines development up to commercial operation

Supporting companies navigate the complex landscape of regulatory requirements from medicine development to commercialization